期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Protective effects of combined Astragalus membranaceus and magnesium ions on global brain ischemia 被引量:1
1
作者 Yifeng Miao Bing Li +3 位作者 Yuchang Lin Xiaojie Lu Bin Wu yongming qiu 《Neural Regeneration Research》 SCIE CAS CSCD 2011年第15期1136-1140,共5页
The traditional Chinese herb Astragalus membranaceus is a well-known treatment for neurological diseases and is considered to exhibit anti-dementia properties.This study investigated the synergistic effects of magnesi... The traditional Chinese herb Astragalus membranaceus is a well-known treatment for neurological diseases and is considered to exhibit anti-dementia properties.This study investigated the synergistic effects of magnesium ions and Astragalus membranaceus on global brain ischemia in rats.4'-6-diamidino-2-phenylindole staining demonstrated that the number of living neurons was significantly greater in the rat hippocampus after administration of a combination of Astragalus membranaceus and magnesium,compared with a vehicle group,an Astragalus membranaceus alone group,and a magnesium alone group.Western blot assay revealed that cleaved Caspase-3 protein expression was significantly reduced in the rat hippocampus in the combined Astragalus membranaceus and magnesium group compared with the Astragalus membranaceus alone group and the magnesium alone group.The results suggested that the combination of Astragalus membranaceus and magnesium exhibits a stronger neuroprotective effect on global brain ischemia in rats compared with Astragalus membranaceus or magnesium alone.This effect was associated with decreased Caspase-3 expression. 展开更多
关键词 global brain ischemia Astragalus membranaceus MAGNESIUM NEUROPROTECTION CASPASE-3 neural regeneration
下载PDF
Dynamic expression of cerebral cortex and hippocampal glutamate transporters in a rat model of chest compression-induced global cerebral ischemia
2
作者 Qinhua Guo Jin Lan +4 位作者 Weiqiao Zhang Pin Guo Liemei Guo Zhiqiang Li yongming qiu 《Neural Regeneration Research》 SCIE CAS CSCD 2012年第2期125-130,共6页
The present study established a rat model of global cerebral ischemia induced by chest compression for six minutes to dynamically observe expressional changes of three glutamate transporters in the cerebral cortex and... The present study established a rat model of global cerebral ischemia induced by chest compression for six minutes to dynamically observe expressional changes of three glutamate transporters in the cerebral cortex and hippocampus. After 24 hours of ischemia, expression of glutamate transporter-1 significantly decreased in the cerebral cortex and hippocampus, which was accompanied by neuronal necrosis. At 7 days post-ischemia, expression of excitatory amino acid carrier 1 decreased in the hippocampal CA1 region and cortex, and was accompanied by apoptosis Expression of glutamate-aspartate transporter remained unchanged at 6 hours 7 days after ischemia. These results suggested that glutamate transporter levels were altered at different periods of cerebral ischemia. 展开更多
关键词 apoptosis excitatory amino acid carrier 1 global cerebral ischemia glutamate-aspartate transporter glutamate transporter glutamate transporter-1 NEUROPROTECTION
下载PDF
中国新诊断胶质母细胞瘤患者实际治疗方案与Stupp方案的一致性比较
3
作者 Yu Wang Jianmin Zhang +27 位作者 Wenbin Li Taipeng Jiang Songtao Qi Zhongping Chen Jingbo Kang Lei Huo Yunjie Wang Qichuan Zhuge Guodong Gao Yuping Wu Hua Feng Gang Zhao Xiaopeng Yang Hui Zhao Yirong Wang Hui Yang Dezhi Kang Jun Su Liang Li Chuanlu Jiang Gang Li yongming qiu Weimin Wang Handong Wang Zaihua Xu Liwei Zhang Renzhi Wang 吴劲松(翻译/校对) 《癌症》 CAS 2022年第8期385-399,共15页
目的评估中国新诊断胶质母细胞瘤(glioblastoma multiforme,GBM)患者实际接受的治疗方案与指南推荐的Stupp方案的一致性。方法纳入202例新诊断GBM患者,评估实际接受的治疗方案与Stupp方案一致的患者比例,以及不符合Stupp方案的原因。结... 目的评估中国新诊断胶质母细胞瘤(glioblastoma multiforme,GBM)患者实际接受的治疗方案与指南推荐的Stupp方案的一致性。方法纳入202例新诊断GBM患者,评估实际接受的治疗方案与Stupp方案一致的患者比例,以及不符合Stupp方案的原因。结果研究发现,仅15.8%的GBM患者接受了与Stupp方案一致的治疗。治疗方案的不一致主要是由于同步放化疗阶段替莫唑胺剂量>75 mg/m^(2)(58/120;48.3%)和治疗持续时间<42 d(84/120;70.0%),以及辅助治疗阶段替莫唑胺剂量<150 mg/m^(2)(89/101;88.1%)。接受符合Stupp方案治疗的患者的中位总生存期(27.09 vs 18.21个月)和无进展生存期(14.27 vs 12.10个月)更长。结论需要提高中国GBM患者实际接受的治疗方案与Stupp方案的一致性。 展开更多
关键词 辅助化疗 一致性 胶质母细胞瘤 胶质瘤 Stupp方案 替莫唑胺
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部